Tangential Flow Filtration for High-Purity RNA Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for RNA purification are inefficient, laborious, and unsuitable for large-scale pharmaceutical-grade production, failing to achieve high purity, stability, and cost-effectiveness, particularly in the presence of contaminants like DNA, proteins, and organic solvents.

Innovation Solution

A method involving tangential flow filtration (TFF) is employed to condition and purify transcribed RNA, utilizing enzymes like DNA-dependent RNA polymerases and restriction endonucleases to process DNA encoding RNA, followed by TFF steps to achieve high purity and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If RNA precipitation is used for purification, then RNA concentration and depletion of contaminants is achieved, but the process is time-consuming and requires organic solvents

Engineering Contradiction:
ImproveRNA purityVSAvoidpurification time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent extracts and removes contaminants from the RNA sample using tangential flow filtration with specifically designed membranes. The TFF system separates RNA from contaminants based on size and charge differences, extracting impurities without requiring precipitation steps, thereby reducing purification time while maintaining high RNA purity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces tangential flow filtration as an intermediary purification step between transcription and formulation. The TFF process acts as a mediator that efficiently removes contaminants without requiring organic solvents or lengthy precipitation protocols, enabling faster processing while achieving pharmaceutical-grade purity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If multiple purification steps are used to achieve high purity, then RNA purity increases, but process complexity and time increase

Engineering Contradiction:
ImproveRNA purityVSAvoidpurification process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent combines concentration and purification functions into a single tangential flow filtration step. The TFF process simultaneously concentrates RNA and removes contaminants in one operation, eliminating the need for multiple separate purification steps and reducing overall process complexity while maintaining high purity standards.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The tangential flow filtration system performs multiple functions including concentration, purification, and buffer exchange in a single platform. This multi-functional approach replaces multiple specialized purification steps, reducing device complexity while achieving the required pharmaceutical-grade RNA purity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If manual sample handling is used for purification, then flexibility is maintained, but labor intensity and time consumption increase

Engineering Contradiction:
Improvepurification flexibilityVSAvoidpurification efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The tangential flow filtration system is designed to automatically perform purification and concentration without extensive manual intervention. The automated TFF process maintains flexibility in handling different RNA types and contamination profiles while significantly reducing labor intensity and increasing overall purification productivity compared to manual methods.

Inventive Principle:
Principle #25Self-service

4Manufacturing precision

If organic solvents are used for precipitation, then contaminant removal is effective, but compatibility with pharmaceutical formulation is compromised

Engineering Contradiction:
Improvecontaminant removal efficiencyVSAvoidformulation compatibility
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent converts the challenge of contaminant removal into a benefit by using tangential flow filtration with charged membranes. Instead of relying on organic solvents that compromise formulation compatibility, the TFF system exploits charge differences to selectively retain or remove contaminants, achieving effective purification while maintaining RNA compatibility with pharmaceutical formulations.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables cost- and time-efficient large-scale RNA production with high yield and pharmaceutical-grade purity, effectively removing contaminants while maintaining RNA stability and functionality.

Implementation Method 1

The present invention relates to methods of tangential flow filtration (TFF) for producing and purifying RNA

Methodology Applied
Scientific EffectTangential flow filtration: Filter (physical)

Implementation Method 2

RNA precipitation allows sample concentration as well as depletion of contaminating high molecular weight contaminants

Methodology Applied
Scientific EffectSize exclusion: Filter (physical)

Implementation Method 3

transcription of the DNA to yield a solution comprising transcribed RNA

Methodology Applied
Scientific EffectTranscription: Enzyme

Implementation Method 4

enzymes like DNA-dependent RNA polymerases and restriction endonucleases to process DNA encoding RNA

Methodology Applied
Scientific EffectRestriction enzyme digestion: Enzyme

Data Source

PatentUS20260043019A1Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
Publication Date: 2026.02.12 CUREVAC REAL ESTATE GMBH
  • US20260043019A1 patent drawing
  • US20260043019A1 patent drawing
  • US20260043019A1 patent drawing

AI summary

The present invention relates to method for producing and purifying RNA comprising the steps of providing DNA encoding the RNA; transcription of the DNA into RNA; and conditioning and/or purifying of the solution comprising transcribed RNA by one or more steps of tangential flow filtration (TFF).